Edition:
India

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

14.09EUR
22 Jun 2018
Change (% chg)

€0.02 (+0.14%)
Prev Close
€14.07
Open
€14.03
Day's High
€14.20
Day's Low
€14.01
Volume
152,220
Avg. Vol
160,399
52-wk High
€14.85
52-wk Low
€10.02

Latest Key Developments (Source: Significant Developments)

Fagron Reports Q1 Turnover At 109.1 Million Euros
Thursday, 12 Apr 2018 

April 12 (Reuters) - Fagron NV ::Q1 TURNOVER EUR 109.1 MILLION VERSUS EUR 109.0 MILLION YEAR AGO.FURTHER GROWTH IN TURNOVER AND PROFITABILITY EXPECTED IN 2018.SEES TURNOVER DEVELOPMENT TO NO LONGER BE NEGATIVELY AFFECTED IN THE CURRENT QUARTER.  Full Article

Cannimed Therapeutics Announces Cannabis Distribution Agreement With Fagron NV
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Cannimed Therapeutics Inc ::CANNIMED THERAPEUTICS INC. ANNOUNCES STRATEGIC INTERNATIONAL CANNABIS DISTRIBUTION AGREEMENT WITH FAGRON NV.CANNIMED THERAPEUTICS INC - ‍ IS WORKING TO SUPPLEMENT ITS CANADIAN GMP COMPLIANT STATUS WITH GMP CERTIFICATION IN EUROPE FOR ITS CANNABIS PRODUCTS.CANNIMED THERAPEUTICS INC - ‍FAGRON AND CANNIMED ANTICIPATE FIRST PRODUCT SALES INTO GERMANY WILL COMMENCE IN Q3 2018​.CANNIMED THERAPEUTICS INC - ‍ PRIMARY INITIAL FOCUS OF CANNABIS DISTRIBUTION AGREEMENT WITH FAGRON NV​ ON GERMANY.CANNIMED THERAPEUTICS- ‍FAGRON TO UTILIZE ITS DISTRIBUTION NETWORK TO MARKET, DISTRIBUTE CANNIMED MEDICINAL CANNABIS PRODUCTS TO 17 SPECIFIED COUNTRIES​.  Full Article

Fagron appoints ‍Rafael Padilla to succeed Hans Stols as CEO
Monday, 27 Nov 2017 

Nov 27 (Reuters) - FAGRON NV ::‍RAFAEL PADILLA SUCCEEDS HANS STOLS AS CEO​.‍MR. STOLS WILL RESIGN FROM ALL HIS FUNCTIONS AND MANDATES WITH IMMEDIATE EFFECT​.  Full Article

Fagron Q3 turnover ‍​up at 103.6 million euros
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - FAGRON NV ::Q3 TURNOVER EUR ‍​103.6 MILLION VERSUS EUR 103.4 MILLION YEAR AGO.BACKLOG IS EXPECTED TO BE LARGELY CLEARED IN THE Q1 OF 2018‍​.  Full Article

Fagron acquires All Chemistry in Brazil
Thursday, 5 Oct 2017 

Oct 5 (Reuters) - FAGRON NV ::FAGRON FURTHER EXECUTES BUY-AND-BUILD STRATEGY WITH ACQUISITION OF ALL CHEMISTRY IN BRAZIL.  Full Article

Fagron appoints Karin de Jong to board of directors
Monday, 17 Oct 2016 

Fagron NV : Karin de Jong joins the board of directors .Board of directors decided to co-opt Karin de Jong as executive director of Fagron.  Full Article

Fagron posts Q3 revenue of 103.4 mln euros, below Reuters poll
Wednesday, 12 Oct 2016 

Fagron NV : Fagron realises turnover of 103.4 million euros ($115.8 million), below 106 million euros seen in Reuters poll . Q3 revenue from continuing operations fell 1.1 percent to 103.4 million euros . Expected that the Wichita facility will have received all required licences and will have completed the validation processes early 2017 . Based on the current operations, Fagron expects to realise a turnover of at least 415 million euros and REBITDA of 85-95 million euros for the FY 2016 .Negative impact of changed reimbursement system on turnover, profitability of freedom pharmaceuticals in US to result in substantial goodwill write-off during the impairment test in Dec. 2016.  Full Article

Fagron: completion of the scrips private placement
Tuesday, 5 Jul 2016 

Fagron NV : Successful completion of the offering / completion of the scrips private placement . Announced that additional 5.38 pct of new shares have been committed to be subscribed to following completion of the private placement of the scrips .The new shares were offered at a ratio of 5 new shares for 16 preferential subscription rights at an issue price of 5.16 euro per new share.  Full Article

Fagron says 94.62 pct take up of rights offering
Tuesday, 5 Jul 2016 

Fagron NV : Says 94.62 pct take up of rights offering . Subscription price at 5.16 euros ($5.74) per new share . At the request of Fagron, the trading of the shares of Fagron on the regulated market of Euronext Brussels and Euronext Amsterdam will be temporarily suspended during the scrips private placement . Payment of issue price, completion of capital increase and delivery and listing of new shares to the markets of Euronext Brussels and Amsterdam is expected to take place on or around July 7, 2016 .New shares were offered at a ratio of 5 new shares for 16 preferential subscription rights.  Full Article

BRIEF-Fagron Reports Q1 Turnover At 109.1 Million Euros

* Q1 TURNOVER EUR 109.1 MILLION VERSUS EUR 109.0 MILLION YEAR AGO